Cargando…

Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus

Mycobacterium abscessus is a difficult respiratory pathogen to treat, when compared to other nontuberculus mycobacteria (NTM), due to its drug resistance. In this study, we aimed to find a new clarithromycin partner that potentiated strong, positive, synergy against M. abscessus among current anti-M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bich Hanh, Bui Thi, Quang, Nguyen Thanh, Park, Yujin, Heo, Bo Eun, Jeon, Seunghyeon, Park, June-Woo, Jang, Jichan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693020/ https://www.ncbi.nlm.nih.gov/pubmed/34955859 http://dx.doi.org/10.3389/fphar.2021.790767

Ejemplares similares

A Screening of the MMV Pandemic Response Box Reveals Epetraborole as A New Potent Inhibitor against Mycobacterium abscessus
por: Kim, Taeho, et al.
Publicado: (2021)

CRISPR Interference-Based Inhibition of MAB_0055c Expression Alters Drug Sensitivity in Mycobacterium abscessus
por: Nguyen, Thanh Quang, et al.
Publicado: (2023)

Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus
por: Quang, Nguyen Thanh, et al.
Publicado: (2021)

Rifamycin O, An Alternative Anti-Mycobacterium abscessus Agent
por: Hanh, Bui Thi Bich, et al.
Publicado: (2020)

Etamycin as a Novel Mycobacterium abscessus Inhibitor
por: Hanh, Bui Thi Bich, et al.
Publicado: (2020)

Thiostrepton: A Novel Therapeutic Drug Candidate for Mycobacterium abscessus Infection
por: Kim, Tae Ho, et al.
Publicado: (2019)

Sirtuin 3 is essential for host defense against Mycobacterium abscessus infection through regulation of mitochondrial homeostasis
por: Kim, Young Jae, et al.
Publicado: (2020)

The Peroxisome Proliferator-Activated Receptor α- Agonist Gemfibrozil Promotes Defense Against Mycobacterium abscessus Infections
por: Kim, Yi Sak, et al.
Publicado: (2020)

Ohmyungsamycin promotes M1-like inflammatory responses to enhance host defence against Mycobacteroides abscessus infections
por: Jeon, Sang Min, et al.
Publicado: (2022)

Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series
por: Pearson, Jeffrey C, et al.
Publicado: (2020)

Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus
por: Bax, Hannelore I, et al.
Publicado: (2019)

Preliminary, Real-world, Multicenter Experience With Omadacycline for Mycobacterium abscessus Infections
por: Morrisette, Taylor, et al.
Publicado: (2021)

Omadacycline for the treatment of Mycobacterium abscessus infections: Case series and review of the literature
por: Siddiqa, Ayesha, et al.
Publicado: (2023)

Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro
por: Li, Anqi, et al.
Publicado: (2023)

Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections
por: Mingora, Christina M, et al.
Publicado: (2023)

Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex
por: Rubio, Marc, et al.
Publicado: (2015)

Correction to: Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections
Publicado: (2023)

Evaluation of omadacycline against intracellular Mycobacterium abscessus in an infection model in human macrophages
por: Jahanbakhsh, S, et al.
Publicado: (2023)

Comment on “Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections”
por: Srivastava, Shashikant, et al.
Publicado: (2023)

Safety and tolerability of long-term use of omadacycline in the treatment of Mycobacterium abscessus infections
por: Srivastava, Shashikant, et al.
Publicado: (2023)

Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro
por: Mukherjee, Devika, et al.
Publicado: (2017)

The Contribution of Efflux Pumps in Mycobacterium abscessus Complex Resistance to Clarithromycin
por: Vianna, Júlia S., et al.
Publicado: (2019)

Rifaximin potentiates clarithromycin against Mycobacterium abscessus in vitro and in zebrafish
por: Goh, Boon Chong, et al.
Publicado: (2023)

Unusually high clarithromycin resistance in Mycobacterium abscessus subsp. abscessus isolated from human gastric epithelium
por: Chouhan, Deepak, et al.
Publicado: (2023)

Pulmonary Mycobacterium abscessus Subspecies abscessus Disease That Showed a Discrepancy Between the Genotype and Phenotype of Clarithromycin Resistance
por: Yamaba, Yusuke, et al.
Publicado: (2019)

Efflux Pumps Contribute to Intrinsic Clarithromycin Resistance in Clinical, Mycobacterium abscessus Isolates
por: Guo, Qi, et al.
Publicado: (2020)

Omadacycline for management of Mycobacterium abscessus infections: a review of its effectiveness, place in therapy, and considerations for use
por: Rizzo, Ashley R., et al.
Publicado: (2022)

Pathogen Box screening for hit identification against Mycobacterium abscessus
por: Jeong, Jinsun, et al.
Publicado: (2018)

The Clarithromycin Susceptibility Genotype Affects the Treatment Outcome of Patients with Mycobacterium abscessus Lung Disease
por: Guo, Qi, et al.
Publicado: (2018)

In Vitro Synergy Testing of Eravacycline in Combination with Clarithromycin and Rifabutin against Mycobacterium abscessus Complex
por: Chew, Ka Lip, et al.
Publicado: (2021)

Evaluation of the Impact of Comorbidities on Omadacycline Pharmacokinetics
por: Trang, M., et al.
Publicado: (2023)

Detection and Assessment of Clarithromycin Inducible Resistant Strains Among Korean Mycobacterium abscessus Clinical Strains: PCR Methods
por: Lee, Seung‐Heon, et al.
Publicado: (2014)

Lack of association between rrl and erm(41) mutations and clarithromycin resistance in Mycobacterium abscessus complex
por: Carneiro, Maiara dos Santos, et al.
Publicado: (2017)

Genetic Evolution of Mycobacterium abscessus Conferring Clarithromycin Resistance during Long-Term Antibiotic Therapy
por: Li, Bing, et al.
Publicado: (2020)

Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus
por: Sudadech, Phantitra, et al.
Publicado: (2021)

Pharmacokinetics, Distribution, Metabolism, and Excretion of Omadacycline following a Single Intravenous or Oral Dose of (14)C-Omadacycline in Rats
por: Lin, Wen, et al.
Publicado: (2016)

Mixed Infection of Mycobacterium abscessus subsp. abscessus and Mycobacterium tuberculosis in the Lung
por: Sohn, Sungmin, et al.
Publicado: (2017)

A real-time PCR assay for rapid identification of inducible and acquired clarithromycin resistance in Mycobacterium abscessus
por: Sharma, Meenu Kaushal, et al.
Publicado: (2020)

Rapid Detection of Clarithromycin and Amikacin Resistance in Mycobacterium abscessus Complex by High-Resolution Melting Curve Analysis
por: Li, Haoran, et al.
Publicado: (2022)

Aortic endograft infection by Mycobacterium abscessus subsp. massiliense with acquired clarithromycin resistance: a case report
por: Akiyama, Yutaro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1v1rq1qn3267vt53kth4upkt4a